Baia Z-G, Bo A, Wu SJ, Gai Q-W, Iris Chi I (2018) Journal of Affective Disorders 2018 Dec, 241: 241-248 doi.org/10.1016/j.jad.2018.07.057
This review suggested the efficacy of n-3 PUFA treatment with dosage greater than 1.5 g/d in reducing depressive symptoms among adults aged 60 or older.
We searched ten databases and gray literature. Nine studies with low risk of bias were included.
This review synthesized the effects of n-3 PUFAs on depressive symptoms among older adults and explored subgroup differences based on participant characteristics and intervention characteristics.